Skip to main content
SpringerLink
Log in

Drug-Induced Acne

  • Chapter
Pathogenesis and Treatment of Acne and Rosacea

  • 3209 Accesses

Abstract

Drug-induced acne (DIA) is an acne-like eruption precipitated or aggravated by certain medication. The culprit drug can be one orally administered, topically applied, or inhaled.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 239.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lobo A, Mathai R, Jacob M. Pathogenesis of drug induced acneform eruptions. Indian J Dermatol Venereol Leprol. 1992;58:159–63.

    Google Scholar 

  2. Plewig G, Jansen T. Acneiform dermatoses. Dermatology. 1998;196:102–7.

    Article  CAS  PubMed  Google Scholar 

  3. Hurwitz RM. Steroid acne. J Am Acad Dermatol. 1989;21(6):1179–81.

    Article  CAS  PubMed  Google Scholar 

  4. Yu HJ, Lee SK, Son SJ, Kim YS, Yang HY, Kim JH. Steroid acne vs. Pityrosporum folliculitis: the incidence of Pityrosporum ovaleand the effect of antifungal drugs in steroid acne. Int J Dermatol. 1998;37(10):772–7.

    Article  CAS  PubMed  Google Scholar 

  5. Mills Jr OH, Leyden JJ, Kligman AM. Tretinoin treatment of steroid acne. Arch Dermatol. 1973;108(3):381–4.

    Article  PubMed  Google Scholar 

  6. Melnik B, Jansen T, Grabbe S. Abuse of anabolic-androgenic steroids and bodybuilding acne: an underestimated health problem. J Dtsch Dermatol Ges. 2007;5(2):110–7.

    Article  PubMed  Google Scholar 

  7. Scott III MJ, Scott AM. Effects of anabolic-androgenic steroids on the pilosebaceous unit. Cutis. 1992;50(2):113–6.

    PubMed  Google Scholar 

  8. Weimann E, Böhles HJ. Acute acne fulminans et conglobata after the end of high-dose testosterone therapy for hereditary tall stature. Klin Padiatr. 1999;211(5):410–2.

    Article  CAS  PubMed  Google Scholar 

  9. Traupe H, von Muehlendahl K, Braemswig J, Happle R. Acne of the fulminans type following testosterone therapy in three excessively tall boys. Arch Dermatol. 1988;124:414–7.

    Article  CAS  PubMed  Google Scholar 

  10. Slayden SM. Risks of menopausal androgen supplementation. Semin Reprod Endocrinol. 1998;16(2):145–52.

    Article  CAS  PubMed  Google Scholar 

  11. Raza S, Baig M, Ali J, Rizvi S. To study hypoactive sexual desire disorder in a fragile X carrier female successfully treated with local testosterone application. Int J Impot Res. 2008;20(2):226–8.

    Article  CAS  PubMed  Google Scholar 

  12. Braunstein GD. Management of female sexual dysfunction in postmenopausal women by testosterone administration: safety issues and controversies. J Sex Med. 2007;4:859–66.

    Article  CAS  PubMed  Google Scholar 

  13. Tsankov N, Kazandjieva J, Drenovska K. Drugs in exacerbation and provocation of psoriasis. Clin Dermatol. 1998;16(3):334–52.

    Google Scholar 

  14. Yeung CK, Chan HH. Cutaneous adverse effects of lithium: epidemiology and management. Am J Clin Dermatol. 2004;5(1):3–8.

    Article  PubMed  Google Scholar 

  15. Plewig G. New concepts of drug induced acne. JEADV. 1995;5 Suppl 1:10.

    Google Scholar 

  16. Aithal V, Appaih P. Lithium induced hidradenitis suppurativa and acne conglobata. Indian J Dermatol Venereol Leprol. 2004;70:307–9.

    PubMed  Google Scholar 

  17. Sharma RP, Kothari AK, Sharma NK. Acneform eruptions and antitubercular drugs. Indian J Dermatol Venereol Leprol. 1995;61:26–7.

    CAS  PubMed  Google Scholar 

  18. Bereston ES. Reactions to antituberculous drugs. J Invest Dermatol. 1959;33:427–39.

    Article  CAS  PubMed  Google Scholar 

  19. Purohit SD, Gupta PR, Sharma TN, Chawla MP, Gupta DN. Acne during rifampicin therapy. Ind J Tub. 1983;30:110–1.

    Google Scholar 

  20. Tsankov N, Kamarashev J. Rifampin in dermatology. Int J Dermatol. 1993;32:401–6.

    Article  CAS  PubMed  Google Scholar 

  21. Ito K, Hoshino H, Nakazono T, Masuyama H, Sugita H, Yoshiyama T, Kato S. Adverse effect other than liver dysfunction in treatment of latent tuberculous infection by isoniazid. Kekkaku. 2007;82(1):1–9.

    PubMed  Google Scholar 

  22. Cohen LK, George W, Smith R. Isoniazid induced acne and pellagra. Occurrence in slow inactivators of isoniazid. Arch Dermatol. 1974;109:377–81.

    Article  CAS  PubMed  Google Scholar 

  23. Jyonouchi H, Lien KW, Aguila H, Spinnato GG, Sabharwal S, Pletcher BA. SAPHO osteomyelitis and sarcoid dermatitis in a patient with DiGeorge syndrome. Eur J Pediatr. 2006;165(6):370–3.

    Article  PubMed  Google Scholar 

  24. Danby FW. Acne and iodine: Reply. J Am Acad Dermatol. 2007;56(1):164–5.

    Article  PubMed  Google Scholar 

  25. Galimont-Collen A, Vos L, Lavrijsen A, Ouwerkerk J, Gelderblom H. Classification and management of skin, hair, nail and mucosal side-effects of epidermal growth factor receptor (EGFR) inhibitors. Eur J Cancer. 2007;43(5):845–51.

    Article  CAS  PubMed  Google Scholar 

  26. Pérez-Soler R, Delord JP, Halpern A, Kelly K, Krueger J, Massutí Sureda B, von Pawel J, Temel J, Siena S, Soulières D, Saltz L, Leyden J. HER1/EGFR inhibitor-associated rash: future directions for management and investigation outcomes from the HER1/EGFR inhibitor rash management forum. Oncologist. 2005;10(5):345–56.

    Article  PubMed  Google Scholar 

  27. Piérard-Franchimont C, Blaise G, Paquet P, Quatresooz R, Rorive A, Piérard GE. Paroxysmal iatrogenic acne and the epidermal growth factor receptor inhibitors. Rev Med Liege. 2007;62(1):11–4.

    PubMed  Google Scholar 

  28. Molinari E, De Quatrebarbes J, André T, Aractingi S. Cetuximab-induced acne. Dermatology. 2005;211:330–3.

    Article  CAS  PubMed  Google Scholar 

  29. Lacouture ME. Mechanisms of cutaneous toxicities to EGFR inhibitors. Nat Rev Cancer. 2006;6(10):803–12.

    Article  CAS  PubMed  Google Scholar 

  30. Gutzmer R, Werfel T, Mao R, Kapp A, Elsner J. Successful treatment with oral isotretinoin of acneiform skin lesions associated with cetuximab therapy. Br J Dermatol. 2005;153:849–51.

    Article  CAS  PubMed  Google Scholar 

  31. Labianca R, La Verde N, Garassino MC. Development and clinical indications of cetuximab. Int J Biol Markers. 2007;22(1 Suppl 4):40–6.

    Google Scholar 

  32. Jansen T, Romiti R, Kreuter A, Altmeyer P. Rosacea fulminans triggered by high-dose vitamins B6 and B12. J Eur Acad Dermatol Venereol. 2001;15(5):484–5.

    Article  CAS  PubMed  Google Scholar 

  33. Dupre A, Albarel N, Bonafe JL, Christol B, Lassere J. Vitamin B-12 induced acnes. Cutis. 1979;24(2):210–1.

    CAS  PubMed  Google Scholar 

  34. Sherertz EF. Acneiform eruption due to “megadose” vitamins B6 and B12. Cutis. 1991;48(2):119–20.

    CAS  PubMed  Google Scholar 

  35. Braun-Falco O, Lincke H. The problem of vitamin B6/B12 acne. A contribution on acne medicamentosa. MMW Munch Med Wochenschr. 1976;118(6):155–60.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Medical University, Sofia, Bulgaria

    Jana Stojanova Kazandjieva & Nikolai Konstantinov Tsankov

Authors
  1. Jana Stojanova Kazandjieva
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nikolai Konstantinov Tsankov
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jana Stojanova Kazandjieva .

Editor information

Editors and Affiliations

  1. Departments of Dermatology, Venereology, Allergology, and Immunology, Dessau Medical Center, Dessau, Germany

    Christos C. Zouboulis

  2. Department of Dermatology, Andreas Syngros Hospital, University of Athens, Athens, Greece

    Andreas D. Katsambas

  3. Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA

    Albert M. Kligman

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Kazandjieva, J.S., Tsankov, N.K. (2014). Drug-Induced Acne. In: Zouboulis, C., Katsambas, A., Kligman, A. (eds) Pathogenesis and Treatment of Acne and Rosacea. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69375-8_33

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-69375-8_33

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-69374-1

  • Online ISBN: 978-3-540-69375-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation